News and Trends 1 Jun 2023
ElevateBio raises $401M for cell and gene therapies
ElevateBio, LLC (ElevateBio), a technology-driven company focused on cell and gene therapies, has closed its $401 million Series D financing. “We have made significant strides in scaling our technologies and…